Hodson, Leanne
Churchill Hospital · University of Oxford · NIHR Oxford Biomedical Research Centre · Oxford Centre for Diabetes, Endocrinology and Metabolism
12 papers on CoChatORCID 0000-0002-2648-6526
Most cited papers
- Verified
Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars
Luukkonen, P. K., Sädevirta, S., Zhou, Y., Kayser, B., Ali, A., Ahonen, L., Lallukka, S., Pelloux, V., Gaggini, M., Jian, C., et al. (2018) · Diabetes Care
Liver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease
Cited by 428
- Verified · note
Downregulation of Adipose Tissue Fatty Acid Trafficking in Obesity
McQuaid, S. E., Hodson, L., Neville, M. J., Dennis, A. L., Cheeseman, J., Humphreys, S. M., Ruge, T., Gilbert, M., Fielding, B. A., Frayn, K. N., et al. (2011) · Diabetes
Lipid metabolism and biosynthesisAdipokines, Inflammation, and Metabolic Diseases
Cited by 366
- Verified
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Yki-Järvinen, H., Luukkonen, P. K., Hodson, L., & Moore, J. B. (2021) · Nature Reviews Gastroenterology & Hepatology
Liver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease
Cited by 294
- Verified
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
Marjot, T., Moolla, A., Cobbold, J. F., Hodson, L., & Tomlinson, J. W. (2020) · Endocrine Reviews
Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects
Cited by 228
- Verified
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
Luukkonen, P. K., Qadri, S., Ahlholm, N., Porthan, K., Männistö, V., Sammalkorpi, H., Penttilä, A. K., Hakkarainen, A., Lehtimäki, T. E., Gaggini, M., et al. (2022) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease
Cited by 170
- Verified
Chronic Palmitate Exposure Inhibits Insulin Secretion by Dissociation of Ca2+ Channels from Secretory Granules
Hoppa, M. B., Collins, S., Ramracheya, R., Hodson, L., Amisten, S., Zhang, Q., Johnson, P., Ashcroft, F. M., & Rorsman, P. (2009) · Cell Metabolism
Pancreatic function and diabetesCellular transport and secretion
Cited by 152
- Verified
Sex-specific differences in hepatic fat oxidation and synthesis may explain the higher Propensity for NAFLD in men
Pramfalk, C., Pavlides, M., Banerjee, R., McNeil, C. A., Neubauer, S., Karpe, F., & Hodson, L. (2015) · The Journal of Clinical Endocrinology & Metabolism
Liver Disease Diagnosis and TreatmentLipid metabolism and biosynthesis
Cited by 138
- Verified
Exercise Prevents Fructose-Induced Hypertriglyceridemia in Healthy Young Subjects
Egli, L., Lecoultre, V., Theytaz, F., Campos, V., Hodson, L., Schneiter, P., Mittendorfer, B., Patterson, B. W., Fielding, B. A., Gerber, P. A., et al. (2013) · Diabetes
Diet, Metabolism, and DiseaseDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 102
- Verified
Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis, compared with young men
Marinou, K., Adiels, M., Hodson, L., Frayn, K. N., Karpe, F., & Fielding, B. A. (2011) · British Journal Of Nutrition
Lipid metabolism and disordersLipid metabolism and biosynthesis
Cited by 75
- Verified
Nuclear receptor REVERBα is a state-dependent regulator of liver energy metabolism
Hunter, A. L., Pelekanou, C. E., Adamson, A., Downton, P., Barron, N. J., Cornfield, T., Poolman, T. M., Humphreys, N., Cunningham, P. S., Hodson, L., et al. (2020) · Proceedings of the National Academy of Sciences
Circadian rhythm and melatoninSirtuins and Resveratrol in Medicine
Cited by 54
- Verified
The isolation of primary hepatocytes from human tissue: Optimising the use of small non-encapsulated liver resection surplus
Green, C. J., Charlton, C. A., Wang, L.-M., Silva, M., Morten, K. J., & Hodson, L. (2017) · Cell and Tissue Banking
Liver physiology and pathologyOrgan Transplantation Techniques and Outcomes
Cited by 43
- Verified
Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
Moolla, A., Poolman, T., Othonos, N., Dong, J., Smith, K., Cornfield, T., White, S., Ray, D. W., Mouchti, S., Mózes, F. E., et al. (2025) · JHEP Reports
Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management
Cited by 33
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free